查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1870487

Erucamide市场：按应用、终端用户产业、产品类型和技术划分－2025-2032年全球预测

Erucamide Market by Application, End Use Industry, Product Type, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，Erucamide市场规模将成长至 3.8539 亿美元，复合年增长率为 4.33%。

关键市场统计数据
基准年 2024 2.7442亿美元
预计年份：2025年 2.8658亿美元
预测年份 2032 3.8539亿美元
复合年增长率 (%) 4.33%

简明扼要地介绍了Erucamide的化学性质、工业效用、加工注意事项以及决策者采取明智行动所需的实用框架。

Erucamide已成为聚合物、润滑剂和表面改质剂中重要的爽滑剂和加工助剂，在製造业领域有着广泛的应用。本执行摘要阐述了Erucamide在现代生产环境中的作用，重点介绍了其理化性质、与聚烯的相容性以及在改善表面触感、摩擦性能和加工稳定性方面的效用。读者将清楚了解Erucamide在价值链中的定位、它如何与常用树脂系统相互作用，以及为什么其规格和采购越来越受到材料工程师和采购负责人的关注。

原料来源的演变、永续性优先事项的调整、监管政策的变化以及加工流程的创新正在重新定义Erucamide的应用和供应链策略。

随着原物料采购管道、永续性优先事项和下游配方偏好同步演变，Erucamide市场格局正在迅速变化。在整个价值链中，原材料采购策略正在调整以应对日益严格的原材料价格波动和生命週期影响审查，这迫使配方师重新评估添加剂的性能标准，并要求供应商提高可追溯性。加工技术和复合技术的进步正在拓展Erucamide的应用范围，使其超越传统的润滑剂应用，从而改善低温迁移控制并提高与先进聚烯共混物的相容性。

2025年美国关税调整对添加剂供应链采购行为、供应商多角化与库存策略的影响

2025年美国关税调整对筹资策略、供应商选择和供应链紧急时应对计画产生了实际的影响。进口关税改变了出口商的相对到岸成本差异，使得采购谈判的重点转向国内製造业的韧性和多元化的供应商网络。因此，买家重新评估了长期的供应商关係，并加快了二级资讯订购流程，以确保供应的连续性。

可操作的細項分析揭示了应用、最终用途产业、产品类型和生产技术如何决定Erucamide的适用性和供应商选择。

细分市场分析揭示了影响Erucamide选择和配方策略的具体应用因素和技术要求。在应用领域内，电缆电线、挤出成型、射出成型和包装薄膜的市场动态各不相同。包装薄膜尤其需要仔细考虑，因为它细分为双轴延伸聚丙烯(BOPP)、高密度聚苯乙烯(HDPE) 和低密度聚乙烯 (LDPE)，每种材料对迁移和透明度都有不同的限制。对于电缆电线应用而言，电气相容性和热稳定性是首要考虑因素；而挤出成型和射出成型则更注重加工窗口的耐久性和母粒系统的均质性。

区域对比分析揭示了美洲、欧洲、中东和非洲以及亚太地区的趋势将如何影响供应可靠性、合规预期和商业策略。

区域趋势将塑造供应链结构、监管摩擦以及製造商和买家必须应对的竞争强度。在美洲，由于地理位置接近性主要聚合物加工商，且高度重视近岸采购，因此对稳定的供应模式和可预测的物流需求日益增长。该地区的生产商往往重视卡车直达工厂的配送模式以及支援准时生产和快速配方切换的供应商伙伴关係。

竞争优势和策略伙伴关係推动了整个艾草酰胺供应链的可靠性、技术差异化和快速认证。

Erucamide价值链中的主要企业兼具卓越的技术、灵活的供应链以及对品质保证的坚定承诺。投资于先进蒸馏和加氢等纯化技术的市场参与企业能够持续实现严格的杂质控制和可重复的产品规格，从而满足高价值应用的需求。同样重要的是，拥有成熟的多模态物流方案和区域仓储设施的公司能够快速应对需求波动和关税相关的干扰。

为製造商和买家提供切实可行的、优先排序的策略倡议，以增强供应韧性、加速产品客製化，并在动态的贸易环境中保护利润率。

产业领导者应优先考虑能够增强韧性并创造商业性优势的实际措施。首先，应实现供应商多元化，以平衡成本、地理风险和品质稳定性。对关键等级产品采用双重采购模式并对区域供应商进行认证，可以减少单点故障。其次，应投资于技术合作，加速产品客製化和与加工商的共同开发，从而缩短新配方上市时间，并实现性能目标的快速迭代。

采用严谨的混合方法研究途径，结合专家访谈、技术文献综述和供应链分析，检验Erucamide的表现和商业性趋势。

本分析的调查方法结合了定性专家访谈、技术文献综述和供应链分析，以全面观点Erucamide的发展趋势。研究重点包括与负责人、製程工程师和物流专家进行讨论，以了解实际应用中的限制因素和应用标准。这些讨论为系统评估生产技术、操作特性和特定应用性能要求奠定了基础。

对Erucamide在绩效、合规性和供应链韧性方面的策略角色进行综合分析，凸显了跨职能决策的必要性。

Erucamide在聚合物添加剂产品组合中占据着重要的地位，它兼顾了材料性能、加工性能和法规遵从性。全面的分析表明，效用，而每个行业领域都面临着独特的技术和商业性压力，这些压力会影响产品设计和采购选择。相关人员使其配方策略与不断变化的法规要求保持一致，并投资于采购多元化和技术改进，就能找到实现商业性稳定和产品差异化的清晰路径。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将艾草酰胺加速整合到可生物降解食品包装薄膜中，可改善其滑爽性能。
  • 市场对油菜籽衍生的生物基Erucamide的需求日益增长，这为其在永续聚合物配方中的应用提供了重要依据。
  • 埃里酰胺奈米技术涂层在提高汽车零件耐腐蚀性方面的进展
  • 日益严格的食品接触法规推动了乙醇酰胺润滑剂纯度水准的提高。
  • 化学品製造商和研究机构进行新的合作，开发生物基取代乙醇酰胺。
  • 策略伙伴关係的重点是扩大利用可再生原料生产Erucamide的规模，以满足市场需求。
  • 将先进分析技术应用于药品包装薄膜中Erucamide的品管

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章Erucamide市场：按应用领域划分

  • 电线电缆
  • 挤压
  • 射出成型
  • 包装膜
    • 双轴延伸聚丙烯
    • 高密度聚苯乙烯
    • 低密度聚乙烯

第九章 依最终用途产业分類的Erucamide市场

  • 车
  • 建造
  • 电学
  • 鞋革业
  • 包装
    • 软包装
    • 工业包装
    • 硬包装

第十章 依产品类型分類的Erucamide市场

  • 颗粒
  • 液体
  • 颗粒
  • 粉末

第十一章Erucamide市场：依技术划分

  • 蒸馏
  • 氢化
  • 溶剂萃取

第十二章Erucamide市场：按地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章Erucamide市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国Erucamide市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • BASF SE
    • Dow Inc.
    • Evonik Industries AG
    • Clariant AG
    • Lonza Group AG
    • Croda International Plc
    • Arkema SA
    • Afton Chemical Corporation
    • Mitsubishi Gas Chemical Company, Inc.
    • Oleon NV
Product Code: MRR-1A1A064C0127

The Erucamide Market is projected to grow by USD 385.39 million at a CAGR of 4.33% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 274.42 million
Estimated Year [2025] USD 286.58 million
Forecast Year [2032] USD 385.39 million
CAGR (%) 4.33%

Concise foundational orientation to erucamide chemistry, industrial utility, processing considerations, and the practical framework decision-makers need for informed actions

Erucamide has emerged as a pivotal slip agent and processing aid in polymers, lubricants, and surface modifiers, with broad relevance across manufacturing verticals. This executive summary frames erucamide's role within contemporary production environments, emphasizing its physicochemical attributes, compatibility with polyolefins, and utility in enhancing surface feel, frictional properties, and processing stability. Readers will gain a clear sense of where erucamide integrates into value chains, how it interacts with typical resin systems, and why material engineers and procurement professionals increasingly focus on its specification and sourcing.

The following content synthesizes technical characteristics with practical considerations for industrial adoption. It bridges laboratory performance with industrial-scale requirements, highlighting manufacturing variables such as melt flow behavior, additive migration, and thermal stability under common processing regimes. The intent is to orient decision-makers to the product's practical benefits and constraints, while setting a shared vocabulary for subsequent sections that address regulatory adjustments, trade environments, segmentation complexity, regional dynamics, and corporate strategies.

How evolving feedstock sources, sustainability priorities, regulatory shifts, and processing innovations are redefining erucamide applications and supply chain strategies

The erucamide landscape is shifting rapidly as raw material pathways, sustainability priorities, and downstream formulation preferences evolve in parallel. Across the value chain, sourcing strategies are adapting to feedstock volatility and increased scrutiny over lifecycle impacts, pushing formulators to reassess additive performance criteria and suppliers to enhance traceability. Advances in processing technologies and compounding approaches have expanded the effective use cases for erucamide beyond traditional slip applications, enabling improved low-temperature migration control and compatibility with advanced polyolefin blends.

Concurrently, regulatory and commercial pressures are accelerating the pursuit of greener chemistries and alternative supply networks. Brand owners are integrating additive-level transparency into their sustainability narratives, which in turn prompts processors to secure verifiable supply chains and consider secondary parameters such as biodegradability profiles and renewable feedstock sourcing. These forces intersect with technological innovation: enhanced distillation and hydrogenation routes alongside solvent extraction refinements have raised the bar for consistency and impurity control, which supports higher-value applications and longer product lifecycles. Together, these shifts are redefining how erucamide is specified, procured, and positioned within product portfolios.

How the 2025 United States tariff adjustments reshaped procurement behavior, supplier diversification, and inventory strategies across additive supply chains

United States tariff adjustments in 2025 created tangible ripple effects across sourcing strategies, supplier selection, and supply chain contingency planning. Import duties altered relative landed cost differentials for exporters and redirected procurement conversations toward domestic production resilience and diversified supplier networks. As a direct consequence, buyers reassessed long-standing supplier relationships and accelerated qualification timelines for secondary sources to preserve continuity of supply.

These tariff-driven dynamics also stimulated deeper collaboration between buyers and manufacturers to redesign procurement contracts with clauses that address duty pass-through, inventory staging, and shared risk for supply interruptions. Logistics planners adjusted inbound routing and inventory positions to reduce exposure to ports and customs treatments that incurred higher duty liabilities. At the same time, manufacturers prioritized near-shoring and investment in local compounding capabilities to minimize import dependency for critical additive volumes. The net effect emphasized operational agility: organizations that integrated tariff scenario planning into sourcing playbooks and stress-tested supplier capacity performed better in maintaining production schedules, while those reliant on a narrow set of foreign suppliers faced more acute short-term disruptions.

Actionable segmentation intelligence revealing how application, end-use industry, product type, and production technology determine erucamide suitability and supplier selection

Segmentation insights illuminate application-specific drivers and technical requirements that influence erucamide selection and formulation tactics. Based on Application, market dynamics vary between Cable & Wire, Extrusion, Injection Molding, and Packaging Films, with the latter category demanding particular attention because Packaging Films subdivide into Biaxial Oriented Polypropylene, High Density Polyethylene, and Low Density Polyethylene, each imposing distinct migration and clarity constraints. Cable & Wire applications prioritize electrical compatibility and thermal stability, whereas extrusion and injection molding emphasize processing window resilience and homogenization in masterbatch systems.

When viewed through the lens of End Use Industry, sectoral priorities further refine product specifications. Automotive applications demand thermal endurance and low-bleed profiles to maintain aesthetic and functional surfaces, while Construction markets value durability and weathering resistance. Electronics & Electrical segments require additive purity to avoid interference with sensitive components, and Footwear & Leather leverage slip and feel improvements to enhance consumer perception. The Packaging vertical, which is analyzed as Flexible Packaging, Industrial Packaging, and Rigid Packaging, places a premium on clarity, anti-blocking performance, and regulatory compliance for food contact when relevant.

Product Type segmentation clarifies handling, formulation, and dosing considerations. Granule, Liquid, Pellet, and Powder forms present distinct advantages and constraints for dosing accuracy, dispersion efficiency, and worker safety. Liquid formats facilitate rapid blending but necessitate solvent management, while granules and pellets typically offer easier handling and consistent dosing in automated compounding lines. Powder forms require enhanced dust control and dispersion technologies to achieve uniform additive distribution.

Technology choices govern production cost profile and impurity control. Distillation routes excel at delivering narrow boiling point fractions and therefore support higher-purity grades, Hydrogenation pathways reduce unsaturation-related instability and can improve color and odor profiles, and Solvent Extraction techniques offer selective removal of undesired constituents. Each technological approach yields trade-offs between capital intensity, environmental footprint, and achievable product performance, shaping supplier capabilities and the technical fit for end-use requirements.

Comparative regional analysis highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence supply reliability, compliance expectations, and commercial strategies

Regional dynamics dictate supply chain architecture, regulatory friction, and the competitive intensity that manufacturers and buyers must navigate. In the Americas, proximity to major polymer converters and a pronounced focus on near-shore sourcing drive demand for consistent supply profiles and logistics predictability. Producers in this region often emphasize truck-to-plant distribution models and supplier partnerships that support just-in-time manufacturing and rapid formulation changes.

Europe, Middle East & Africa present a diverse regulatory and market landscape where sustainability mandates and stringent product stewardship expectations shape purchasing behavior. Chemical regulations and extended producer responsibility frameworks encourage producers to highlight traceability and impurity control. In these markets, local compliance, certifications, and demonstrated lifecycle assessments play a larger role in procurement qualification than in some other regions.

Asia-Pacific encompasses varied production bases and a dense concentration of polymer processing capacity, which sustains a broad set of erucamide application opportunities. Manufacturing hubs within this region frequently leverage integrated supply chains that offer scale advantages, while regional demand exhibits rapid responsiveness to changes in consumer packaging trends and industrial expansion. Across all regions, cross-border logistics complexity, lead-time sensitivity, and differing regulatory thresholds converge to influence supplier selection and risk management strategies.

Competitive company attributes and strategic partnerships that drive reliability, technical differentiation, and faster qualification across the erucamide supply chain

Leading companies in the erucamide value chain exhibit a combination of technical excellence, supply chain flexibility, and a clear posture on quality assurance. Market participants that invest in refining technology, such as advanced distillation and hydrogenation capabilities, consistently achieve tighter impurity controls and more reproducible product specifications that appeal to high-value applications. Equally important, firms that establish multi-modal logistics options and regional warehousing can respond more rapidly to shifts in demand or tariff-related disruptions.

Strategic partnerships between additive producers and resin converters or compounders strengthen route-to-market effectiveness and shorten qualification cycles for end-users. Companies that offer formulation support, application testing, and co-development services differentiate themselves by reducing the integration friction for processors. Transparency around batch traceability, certificates of analysis, and adherence to relevant regulatory frameworks further enhances supplier credibility, especially when brand owners require verifiable supply chain information for sustainability reporting and compliance audits.

Practical and prioritized strategic moves for manufacturers and buyers to build supply resilience, accelerate product customization, and protect margins in a dynamic trade environment

Industry leaders should prioritize a set of actionable moves that enhance resilience and create commercial advantage. First, diversify supplier footprints to balance cost, geographic exposure, and quality consistency; dual-sourcing critical grades and qualifying regional suppliers reduces single-point failures. Second, invest in technical partnerships that accelerate product customization and co-development with converters, thereby shortening time-to-market for new formulations and enabling rapid iteration on performance targets.

Third, embed tariff and trade scenario planning into procurement playbooks to ensure pricing and logistics strategies remain adaptable. This involves establishing inventory buffers at strategic nodes, negotiating flexible contract terms with suppliers, and exploring bonded or free-trade arrangements where appropriate. Fourth, elevate documentation and traceability practices to support regulatory compliance and sustainability narratives; clear certificates of analysis, material origin data, and process transparency strengthen customer trust and facilitate market access in stricter regulatory environments. Finally, pursue targeted capital investment in refining and purification technologies to improve grade consistency and enable movement into higher-margin applications that demand low impurity and stable migration behavior.

Rigorous mixed-method research approach integrating expert interviews, technical literature review, and supply chain mapping to validate erucamide performance and commercial dynamics

The research methodology underpinning this analysis combined qualitative expert interviews, technical literature review, and supply chain mapping to generate a comprehensive perspective on erucamide dynamics. Primary engagements included discussions with formulators, procurement leads, process engineers, and logistics specialists to capture real-world constraints and adoption criteria. These conversations informed a structured assessment of production technologies, handling characteristics, and application-specific performance requirements.

Secondary research consolidated publicly available technical papers, regulatory documents, and patent filings to validate observed trends and identify technological maturation in distillation, hydrogenation, and solvent extraction processes. Supply chain mapping integrated customs data patterns and logistics route analysis to surface sensitivity points related to tariff changes and regional lead times. Throughout, analytical rigor focused on triangulating evidence across sources to ensure the conclusions reflect operational realities and not isolated anecdotes.

Synthesis of erucamide's strategic role across performance, compliance, and supply resilience that underscores the need for integrated cross-functional decision-making

Erucamide occupies a critical niche in polymer additive portfolios where material performance, processing behavior, and regulatory compliance intersect. The cumulative picture shows a material whose utility extends across multiple industrial domains, each with distinct technical and commercial pressures that influence product design and sourcing choices. Stakeholders that align formulation strategy with evolving regulatory expectations and invest in diversified sourcing and technological refinement will find clearer pathways to commercial stability and product differentiation.

Looking ahead, the interplay between supply chain resilience, technological advancement, and sustainability commitments will determine which participants capture the most value. Organizations that treat additive strategy as integral to product performance and supply continuity-rather than as a low-touch procurement item-will achieve stronger outcomes in both operational reliability and end-customer satisfaction. This conclusion underscores the importance of cross-functional alignment among R&D, procurement, and commercial teams to translate insight into action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Escalating integration of erucamide in biodegradable food packaging films to enhance slip properties
  • 5.2. Rising demand for bio-based erucamide derived from rapeseed oil for sustainable polymer formulations
  • 5.3. Advancements in erucamide nanotechnology coatings for enhanced corrosion resistance in automotive parts
  • 5.4. Impact of stringent food contact regulations driving innovations in erucamide slip agent purity levels
  • 5.5. Emerging collaborations between chemical manufacturers and research institutes for bio-derived erucamide alternatives
  • 5.6. Strategic partnerships focusing on scaling production of erucamide from renewable feedstocks to meet market demand
  • 5.7. Integration of advanced analytical techniques for erucamide quality control in pharmaceutical packaging films

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Erucamide Market, by Application

  • 8.1. Cable & Wire
  • 8.2. Extrusion
  • 8.3. Injection Molding
  • 8.4. Packaging Films
    • 8.4.1. Biaxial Oriented Polypropylene
    • 8.4.2. High Density Polyethylene
    • 8.4.3. Low Density Polyethylene

9. Erucamide Market, by End Use Industry

  • 9.1. Automotive
  • 9.2. Construction
  • 9.3. Electronics & Electrical
  • 9.4. Footwear & Leather
  • 9.5. Packaging
    • 9.5.1. Flexible Packaging
    • 9.5.2. Industrial Packaging
    • 9.5.3. Rigid Packaging

10. Erucamide Market, by Product Type

  • 10.1. Granule
  • 10.2. Liquid
  • 10.3. Pellet
  • 10.4. Powder

11. Erucamide Market, by Technology

  • 11.1. Distillation
  • 11.2. Hydrogenation
  • 11.3. Solvent Extraction

12. Erucamide Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Erucamide Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Erucamide Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BASF SE
    • 15.3.2. Dow Inc.
    • 15.3.3. Evonik Industries AG
    • 15.3.4. Clariant AG
    • 15.3.5. Lonza Group AG
    • 15.3.6. Croda International Plc
    • 15.3.7. Arkema S.A.
    • 15.3.8. Afton Chemical Corporation
    • 15.3.9. Mitsubishi Gas Chemical Company, Inc.
    • 15.3.10. Oleon NV

LIST OF FIGURES

  • FIGURE 1. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ERUCAMIDE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ERUCAMIDE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ERUCAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ERUCAMIDE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GCC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. GCC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 284. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 285. GCC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 288. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 289. GCC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 323. G7 ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. G7 ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 326. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 327. G7 ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 328. G7 ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. NATO ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. NATO ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 340. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 341. NATO ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 342. NATO ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 343. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 344. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 345. NATO ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. NATO ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. NATO ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 348. NATO ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 349. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. UNITED STATES ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. UNITED STATES ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 354. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 355. UNITED STATES ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 356. UNITED STATES ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 357. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 358. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 359. UNITED STATES ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 360. UNITED STATES ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 361. UNITED STATES ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 362. UNITED STATES ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 363. CANADA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 364. CANADA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 365. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 366. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 367. CANADA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 368. CANADA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 369. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 370. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 371. CANADA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 372. CANADA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 373. CANADA ERUCAMIDE MARKET S